Amendment to Schedule 13G for Athira Pharma, Inc.
2025-10-10SEC Filing  SCHEDULE 13G/A  (0001376474-25-000840)
This filing is an amendment to Schedule 13G for Athira Pharma, Inc., submitted by Steven Michael Oliveira, Neaman Asset Management, LLC, South Ocean Capital LLC, and South Ocean Capital Management LLC. The amendment reports beneficial ownership of 161,218 shares of common stock, representing 4.088% of the total shares. Steven Oliveira holds shared voting and dispositive power over all 161,218 shares, while Neaman Asset Management, LLC holds 151,218 shares, and South Ocean Capital LLC holds 10,000 shares. The filing certifies that the securities were not acquired for the purpose of influencing the control of the issuer.
Tickers mentioned in this filing:ATHA
The link to the original SEC document:https://www.sec.gov/Archives/edgar/data/1620463/0001376474-25-000840.txt